Skip to search boxSkip to navigationSkip to main content

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

  • R. W. Chesnut(corresponding author)
    ,
  • A. Sette
    ,
  • E. Celis
    ,
  • P. Wentworth
    ,
  • R. T. Kubo
    ,
  • J. Alexander
*Corresponding author for this work
  • Cytel Corporation
Scholary Output:
Contribution to journal
Review article
 Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 847-874 (28 pages)

Journal (Volume, Issue Number)

Pharmaceutical biotechnology (Volume 6)

Publication milestones

  • Published - 1995

Publication status

Published - 1995

ISSN

1078-0467

Publication IDs

  • Scopus: 0029178025
  • PubMed: 7551252

Access to documents

Publication metrics

Metrics

Scopus
citations
20, opens in new tab
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
20
Captures
2

Funding Details

FunderFunding number
NIAID
R01AI018634